Analyst Ratings for ADMA Biologics (ADMA)

ADMA Rating Summary

ADMA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ADMA
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $5.50 (+329.7%) * Over Last 12-Mos
Rating Score: 8.9 / 10   Percentile Rank: 88%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/11/2021 Raymond James Elliot Wilbur Upgrade Outperform
(Outperform)
5.00
(N/A)
1.42
(1.28)
-9.86% Details
11/9/2021 Cantor Fitzgerald Kristen Kluska New Coverage Overweight
(N/A)
4.50
(N/A)
1.36
(1.28)
-5.88% Details
Like ADMA Ratings? Also take a look at HAE

ADMA Ratings News